by Karen Weintraub | Jul 25, 2023 | Blog
LEQEMBI is a newly approved drug by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease. According to the FDA, “Alzheimer’s disease is an irreversible, progressive brain disorder affecting more than 6.5 million Americans that slowly...
by Karen Weintraub | Jun 28, 2023 | Blog
Yes, there is a new bar in town and not the kind you think. They are known as IV Drip bars. You can get IV fluids at these trendy concierge IV Drip bars, in the comfort of your own home, at drip parties or almost any location nowadays with the mobile services. Many...
by Karen Weintraub | Jun 6, 2023 | Podcast
Season 4 will be a series of interviews with members of our own Special Investigations Unit. We will showcase different members of our team including the director, investigators, coders and clinicians who will join each episode for a fun reflective chat on their first...
by Karen Weintraub | May 9, 2023 | Blog
What is an HCC? An HCC is a Hierarchical Condition Category which is used to calculate risk scores that may predict the future cost of healthcare for enrollees. HCCs were implemented by the Centers for Medicare and Medicaid (CMS) and have been adopted by Medicare...
by Karen Weintraub | Apr 25, 2023 | Podcast
Season 4 will be a series of interviews with members of our own Special Investigations Unit. We will showcase different members of our team including the director, investigators, coders and clinicians who will join each episode for a fun reflective chat on their first...
